GO:0038113 interleukin-9-mediated signaling pathway

The interleukin-9-mediated signaling pathway (GO:0038113) is a biological process defined as the series of molecular signals initiated by interleukin-9 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. IL-9 is a pleiotropic cytokine produced by T helper 9 (Th9) cells, mast cells, and other cell types, and its receptor is a heterodimer of the IL-9 receptor alpha chain (IL9R) and the common gamma chain (IL2RG). This pathway is critical for immune cell proliferation, survival, and effector functions, and its dysregulation is implicated in allergic inflammation, autoimmunity, and lymphoid malignancies. Understanding the molecular details of IL-9-mediated signaling is essential for researchers studying cytokine biology, immune cell development, and cancer. The cytoplasmic domains of IL9R are particularly important: mutational analysis has shown that distinct regions of the IL9R alpha chain are required for IL-9-mediated cell proliferation and signal transduction. This makes the pathway a prime target for functional genomics and CRISPR-based interrogation. In this article, we provide a research-grade overview of GO:0038113, covering its definition, core mechanism, key genes, disease relevance, and experimental methods. All statements are grounded in the QuickGO definition and verified PubMed literature.

GO:0038113 (interleukin-9-mediated signaling pathway) is the series of molecular signals initiated by interleukin-9 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. It is a biological_process term in the Gene Ontology, with synonyms including IL-9-mediated signaling pathway and interleukin-9-mediated signalling pathway.

GO:0038113 is important because IL-9-mediated signaling controls fundamental immune cell behaviors such as proliferation, survival, and cytokine production, and its dysregulation contributes to allergic inflammation, autoimmune diseases, and lymphoid cancers. The pathway's dependence on specific cytoplasmic domains of the IL-9 receptor alpha chain makes it a tractable model for dissecting structure-function relationships in cytokine signaling.

The following genes and proteins are central to the interleukin-9-mediated signaling pathway (GO:0038113) based on verified literature.

The interleukin-9-mediated signaling pathway is regulated at multiple levels. Cytoplasmic domains of the IL9R alpha chain are essential for transmitting proliferative and signaling outputs, and their mutation can abolish pathway activity. Negative feedback is provided by SOCS proteins, which dampen JAK-STAT signaling. The pathway also crosstalks with PI3K-AKT and MAPK cascades, which modulate survival and proliferation.

IL-9-mediated signaling promotes mast cell and T helper 9 cell responses that drive allergic inflammation. Dysregulated IL-9R signaling contributes to asthma pathogenesis.

Aberrant IL-9 signaling enhances T cell activation and autoantibody production, contributing to autoimmune pathology. Targeting IL9R cytoplasmic domains may offer therapeutic strategies.

IL-9 and its receptor are implicated in T cell lymphomas and other lymphoid cancers, where constitutive signaling supports proliferation and survival. The IL9R alpha chain cytoplasmic domain is critical for these oncogenic effects.

Genome-wide CRISPR knockout screens can identify genes required for IL-9-mediated signaling and proliferation. This approach is unbiased and scalable for pathway discovery.

Introducing point mutations into the cytoplasmic domains of IL9R allows precise mapping of residues required for signal transduction. Such studies have defined critical domains for IL-9-mediated proliferation.

RNA-seq and reporter assays measure transcriptional changes downstream of IL-9 signaling. These methods quantify pathway output and identify target genes.

Mass spectrometry-based proteomics can capture phosphorylation events triggered by IL-9 receptor activation. This reveals signaling nodes and crosstalk.

Researchers studying interleukin-9-mediated signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activity, immune cell proliferation, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to accelerate this discovery process.

GO:0038113 (interleukin-9-mediated signaling pathway) is a well-defined biological process that connects IL-9 cytokine binding to downstream transcriptional regulation. The IL-9 receptor alpha chain and its cytoplasmic domains are central to this pathway, and their dysfunction is linked to allergic, autoimmune, and malignant diseases. Researchers can leverage CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with screening and bioinformatics, to dissect the causal roles of pathway components. EDITGENE offers end-to-end services to accelerate these discoveries.